EUVIMEDEUVIMED entdecken
Crossref

Assessment of Neudesin Serum Levels in Pre-Diabetes and Newly Diagnosed Type 2 Diabetes Mellitus

Saif A. Abdul Haleem, Mohammed I. Hamzah, Mahmood S. Khudhai, Esraa Q. Deli

Iraqi Journal of Medical Sciences · 01.06.2026 · 24 (1) · 10-16

DOI: 10.22578/6f43y497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iraqi Journal of Medical Sciences, online erschienen am 01.06.2026. Verfasst von Saif A. Abdul Haleem und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background:Type 2 Diabetes Mellitus (T2DM) is a metabolic disorder characterized by chronic hyperglycemia due to insulin resistance and impaired insulin secretion. Prediabetes, an intermediary condition where blood glucose levels are elevated but not yet diagnostic for diabetes, poses a significant risk for progression to T2DM. Neudesin (NENF), a neurotrophic factor with known roles in adipocyte differentiation and myoblast inhibition, has emerged as a potential biomarker for metabolic dysregulation.

Objective

To evaluate serum NENF levels in individuals with prediabetes and T2DM, and establish a diagnostic cutoff value with optimal sensitivity and specificity to distinguish diabetic and prediabetic patients from healthy individuals.

Methods

A total of 120 Iraqi individuals aged 28–66 years participated in this study, including 30 patients with T2DM, 30 individuals with prediabetes, and 60 healthy controls. Serum levels of NENF were determined using a commercially available enzyme-linked immunosorbent assay kit, body mass index was calculated from participant height and weight, fasting blood glucose and glycated hemoglobin were measured using standard enzymatic colorimetric methods.

Results

The findings revealed significantly higher serum NENF levels in T2DM patients compared to prediabetic and control groups (P <0.001). Mean NENF concentrations were 651.61±184.08 ng/ml in healthy controls, 745.56±231.23 ng/ml in prediabetic individuals, and 1034.78±496.45 ng/ml in T2DM patients.

Conclusion

Elevated NENF levels are associated with T2DM and prediabetes, suggesting its potential as a sensitive and precise biomarker for early detection, screening, and monitoring of metabolic dysregulation. Keywords: Type 2 diabetes mellitus, neudesin, prediabetes, metabolic dysregulation

Zitieren

APA

Haleem, S. A. A., Hamzah, M. I., Khudhai, M. S., & Deli, E. Q. (2026). Assessment of Neudesin Serum Levels in Pre-Diabetes and Newly Diagnosed Type 2 Diabetes Mellitus. Iraqi Journal of Medical Sciences, 24(1), 10-16. https://doi.org/10.22578/6f43y497

Vancouver

Haleem SAA, Hamzah MI, Khudhai MS, Deli EQ. Assessment of Neudesin Serum Levels in Pre-Diabetes and Newly Diagnosed Type 2 Diabetes Mellitus. Iraqi Journal of Medical Sciences. 2026;24(1):10-16. doi:10.22578/6f43y497

BibTeX
@article{Haleem2026,
  author = {Haleem, Saif A. Abdul and Hamzah, Mohammed I. and Khudhai, Mahmood S. and Deli, Esraa Q.},
  title = {Assessment of Neudesin Serum Levels in Pre-Diabetes and Newly Diagnosed Type 2 Diabetes Mellitus},
  journal = {Iraqi Journal of Medical Sciences},
  year = {2026},
  volume = {24},
  number = {1},
  pages = {10--16},
  doi = {10.22578/6f43y497}
}
Kostenlos starten →